Voyageur Pharmaceuticals Ltd. (VM)
Voyageur Pharmaceuticals Ltd. is a diversified issuer with ~67.9% warrant dilution, 2 recent financings, and recent insider activity.
Price chart
- Ticker
- VM
- Exchange
- TSXV
- Primary commodity
- diversified
- Sector
- mining
- Shares outstanding
- 179,475,866 As of 2026-06-22
Warrant overhang
5 active warrant series covering 121,866,486 shares (~67.9% potential dilution); nearest expiry 2027-05-21.
View warrant overhang tool →Dilution-true chart
Price history with the company's active warrant supply walls (amber) and free-trading unlock dates (violet) overlaid. Levels and dates are Pacific Time.
Recent financings
- private placementCA$5,005,278@ 0.1/unit· closed 2026-06-05source →
- private placementCA$7,500,000@ 0.1/unit· closed 2026-06-04source →
Latest insider transaction
200,000 shares ($40,000) on 2026-06-05.
View insider activity →Recent news
Latest coverage: 20 days ago
- Voyageur Pharmaceuticals Engages Fluor to Advance Feasibility Studies for Iodine Production and Integrated Contrast Drug Manufacturing Facilityquotemedia_thenewswire · 2026-06-23
- Voyageur Pharmaceuticals Evaluating Three Locations in the United States for Integrated Iodine and Barium Contrast Media Manufacturing Facility, a Multi-Phase Investment Expected to Generate Significant Economic Impact and High-Skilled Jobs; Competitive Site Selection Process Underwayquotemedia_thenewswire · 2026-06-18
- Voyageur Pharmaceuticals Ltd. Submits Multi-Year Area-Based Exploration Permit Application for Bulk Sampling and Feasibility Support at Frances Creek Barite Projectquotemedia_thenewswire · 2026-06-10
Profile assembled from Strikepoint News signal data — drill results, warrant filings, financings, insider transactions, and news. Drill rock value per tonne is the gross in-situ value at today's spot prices, recomputed live. This page is for informational purposes only and is not investment advice; verify against the original filings before drawing conclusions.